SCHEMBL22097093

SCHEMBL22097093

c1ccc(-c2cc(-c3ccc(-c4ccc5c(c4)c4ccccc4c4ccc6c(c7ccccc7n6-c6ccccc6)c45)cc3)nc(-c3ccc(-c4ccncc4)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.37
KMT2A Q03164 6/20 0.37
MEN1 O00255 5/20 0.37
DHODH Q02127 1/20 0.37
HSP90AA1 P07900 1/20 0.37
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 3/20 0.36
NTSR1 P30989 1/20 0.36
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MKNK1 Q9BUB5 1/20 0.34
PIK3CA P42336 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22097236 0.95 MAPT (0.39) MAPTKMT2AMEN1HSP90AA1ALDH1A1
SCHEMBL22097148 0.93 MAPT (0.39) MAPTKMT2AMEN1HSP90AA1ALDH1A1
SCHEMBL22097270 0.92 MEN1 (0.40) MAPTKMT2AMEN1DHODHALDH1A1
SCHEMBL22097193 0.92 MEN1 (0.40) MAPTKMT2AMEN1DHODHALDH1A1
SCHEMBL22096968 0.91 MEN1 (0.40) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL22097056 0.91 MEN1 (0.40) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL22097247 0.91 MAPT (0.37) MAPTKMT2AMEN1DHODHHSP90AA1
SCHEMBL22097243 0.90 KDM4E (0.41) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL22097119 0.90 DHODH (0.37) MAPTKMT2AMEN1DHODHALDH1A1
SCHEMBL17853526 0.88 KDM4E (0.44) MAPTKMT2AMEN1DHODHHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 MAPT 508/4885KMT2A 2500/4885MEN1 1207/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 MAPT 508/4885KMT2A 2500/4885MEN1 1207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.